High mesothelin expression is associated with low cytotoxic T cell infiltration in pancreatic cancer.
Saved in:
| Title: | High mesothelin expression is associated with low cytotoxic T cell infiltration in pancreatic cancer. |
|---|---|
| Authors: | Liang O; Precision Oncology Laboratory, Cancer Innovations, Centenary Institute, Sydney, NSW, Australia.; School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., White AL; Precision Oncology Laboratory, Cancer Innovations, Centenary Institute, Sydney, NSW, Australia.; School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Fielder T; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, NSW Health Pathology, Sydney, NSW, Australia., Shin JS; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, NSW Health Pathology, Sydney, NSW, Australia.; Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Sagnella SM; Precision Oncology Laboratory, Cancer Innovations, Centenary Institute, Sydney, NSW, Australia.; Cell and Molecular Therapies, Royal Prince Alfred Hospital, Sydney Local Health District, Sydney, NSW, Australia., Schmitz U; Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Computational Biomedicine Lab, College of Science and Engineering, James Cook University, Townsville, QLD, Australia., Yeo D; Precision Oncology Laboratory, Cancer Innovations, Centenary Institute, Sydney, NSW, Australia.; School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Cell and Molecular Therapies, Royal Prince Alfred Hospital, Sydney Local Health District, Sydney, NSW, Australia. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Oct 08; Vol. 16, pp. 1651687. Date of Electronic Publication: 2025 Oct 08 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41132647 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: High mesothelin expression is associated with low cytotoxic T cell infiltration in pancreatic cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Liang+O%22">Liang O</searchLink>; Precision Oncology Laboratory, Cancer Innovations, Centenary Institute, Sydney, NSW, Australia.; School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22White+AL%22">White AL</searchLink>; Precision Oncology Laboratory, Cancer Innovations, Centenary Institute, Sydney, NSW, Australia.; School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Fielder+T%22">Fielder T</searchLink>; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, NSW Health Pathology, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Shin+JS%22">Shin JS</searchLink>; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, NSW Health Pathology, Sydney, NSW, Australia.; Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Sagnella+SM%22">Sagnella SM</searchLink>; Precision Oncology Laboratory, Cancer Innovations, Centenary Institute, Sydney, NSW, Australia.; Cell and Molecular Therapies, Royal Prince Alfred Hospital, Sydney Local Health District, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Schmitz+U%22">Schmitz U</searchLink>; Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Computational Biomedicine Lab, College of Science and Engineering, James Cook University, Townsville, QLD, Australia.<br /><searchLink fieldCode="AU" term="%22Yeo+D%22">Yeo D</searchLink>; Precision Oncology Laboratory, Cancer Innovations, Centenary Institute, Sydney, NSW, Australia.; School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Cell and Molecular Therapies, Royal Prince Alfred Hospital, Sydney Local Health District, Sydney, NSW, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2025 Oct 08; Vol. 16, pp. 1651687. <i>Date of Electronic Publication: </i>2025 Oct 08 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41132647 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2025.1651687 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1651687 Titles: – TitleFull: High mesothelin expression is associated with low cytotoxic T cell infiltration in pancreatic cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Liang O – PersonEntity: Name: NameFull: White AL – PersonEntity: Name: NameFull: Fielder T – PersonEntity: Name: NameFull: Shin JS – PersonEntity: Name: NameFull: Sagnella SM – PersonEntity: Name: NameFull: Schmitz U – PersonEntity: Name: NameFull: Yeo D IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 10 Text: 2025 Oct 08 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 16 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |